Canadian Imperial Bank of Commerce (CIBC) has filed to issue 4,497,798 units of Accelerated Return Notes linked to a basket of three prominent financial sector stocks. This filing, dated November 2, 2026, highlights CIBC's strategy to diversify its financial products and cater to investors looking for leveraged returns.
The Accelerated Return Notes are priced at $10 per unit, with a maturity date set for December 22, 2027. The notes offer a unique structure where investors can gain 3-to-1 upside exposure to increases in the underlying stocks, which include The Goldman Sachs Group, Inc., JPMorgan Chase & Co., and Morgan Stanley. However, they also entail a risk of losing up to 100% of the principal if the stocks perform poorly.
Background
CIBC is a leading financial institution in Canada, classified under the Standard Industrial Classification (SIC) 6029, which encompasses commercial banks not elsewhere classified. The bank is publicly traded on the New York Stock Exchange (NYSE) under the ticker CM and on the OTC market as CNDIF. Recent filings include a 424B2 and a 6-K, both submitted on November 2, 2026.
What the Filing Says
The filing indicates that the notes are being issued under Rule 424(b)(2) and are not guaranteed by any governmental agency. It states, "The notes will rank equally with all of our other unsecured and unsubordinated debt." The initial estimated value of the notes is $9.614 per unit, which is less than the public offering price.
Impact
This issuance may significantly impact retail investors seeking exposure to the financial sector, as well as institutional investors looking for innovative investment products. The performance of these notes will be closely monitored, especially given the credit risk associated with CIBC itself.
What's Next
Details were not available in the SEC filing regarding future actions following this issuance. However, the market will likely keep a close eye on the performance of the Accelerated Return Notes as they approach their maturity date.
Read Next
Delta Air Lines officer files to sell 44,950 shares
Aspen Neuroscience reports major stock transactions by director
Aspen Neuroscience Reports Major Stock Transactions by Investors
John P. Reed files to sell 179,020 shares of Arhaus, Inc.
Webull Corp Officer Files to Sell 107,692 Shares
Fermi Inc. files to sell 94,000 shares of common stock










